Fuse Medical Stock Probability of Future Pink Sheet Price Finishing Over 0.082

FZMD Stock  USD 0.12  0.07  140.00%   
Fuse Medical's future price is the expected price of Fuse Medical instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Fuse Medical performance during a given time horizon utilizing its historical volatility. Check out Fuse Medical Backtesting, Fuse Medical Valuation, Fuse Medical Correlation, Fuse Medical Hype Analysis, Fuse Medical Volatility, Fuse Medical History as well as Fuse Medical Performance.
  
Please specify Fuse Medical's target price for which you would like Fuse Medical odds to be computed.

Fuse Medical Target Price Odds to finish over 0.082

The tendency of Fuse Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay above $ 0.08  in 90 days
 0.12 90 days 0.08 
about 11.73
Based on a normal probability distribution, the odds of Fuse Medical to stay above $ 0.08  in 90 days from now is about 11.73 (This Fuse Medical probability density function shows the probability of Fuse Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Fuse Medical price to stay between $ 0.08  and its current price of $0.12 at the end of the 90-day period is about 11.58 .
Given the investment horizon of 90 days Fuse Medical has a beta of -6.35. This usually indicates as returns on its benchmark rise, returns on holding Fuse Medical are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Fuse Medical is expected to outperform its benchmark. In addition to that Fuse Medical has an alpha of 5.6992, implying that it can generate a 5.7 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Fuse Medical Price Density   
       Price  

Predictive Modules for Fuse Medical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Fuse Medical. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.010.1243.14
Details
Intrinsic
Valuation
LowRealHigh
0.000.0843.10
Details
Naive
Forecast
LowNextHigh
00.1443.16
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.010.060.11
Details

Fuse Medical Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Fuse Medical is not an exception. The market had few large corrections towards the Fuse Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Fuse Medical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Fuse Medical within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
5.70
β
Beta against Dow Jones-6.35
σ
Overall volatility
0.02
Ir
Information ratio 0.13

Fuse Medical Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Fuse Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Fuse Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Fuse Medical is way too risky over 90 days horizon
Fuse Medical has some characteristics of a very speculative penny stock
Fuse Medical appears to be risky and price may revert if volatility continues
Fuse Medical has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
The company reported the previous year's revenue of 20.41 M. Net Loss for the year was (1.59 M) with profit before overhead, payroll, taxes, and interest of 11.94 M.
Fuse Medical currently holds about 604 K in cash with (1.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Roughly 88.0% of the company shares are held by company insiders
Latest headline from thelincolnianonline.com: Acquisition by Frederick Sullivan of 124933 shares of Senseonics Holdings at 0.38 subject to Rule 16b-3

Fuse Medical Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Fuse Pink Sheet often depends not only on the future outlook of the current and potential Fuse Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Fuse Medical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding70.2 M
Cash And Short Term Investments553.2 K

Fuse Medical Technical Analysis

Fuse Medical's future price can be derived by breaking down and analyzing its technical indicators over time. Fuse Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Fuse Medical. In general, you should focus on analyzing Fuse Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Fuse Medical Predictive Forecast Models

Fuse Medical's time-series forecasting models is one of many Fuse Medical's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Fuse Medical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Fuse Medical

Checking the ongoing alerts about Fuse Medical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Fuse Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Fuse Medical is way too risky over 90 days horizon
Fuse Medical has some characteristics of a very speculative penny stock
Fuse Medical appears to be risky and price may revert if volatility continues
Fuse Medical has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
The company reported the previous year's revenue of 20.41 M. Net Loss for the year was (1.59 M) with profit before overhead, payroll, taxes, and interest of 11.94 M.
Fuse Medical currently holds about 604 K in cash with (1.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Roughly 88.0% of the company shares are held by company insiders
Latest headline from thelincolnianonline.com: Acquisition by Frederick Sullivan of 124933 shares of Senseonics Holdings at 0.38 subject to Rule 16b-3

Other Information on Investing in Fuse Pink Sheet

Fuse Medical financial ratios help investors to determine whether Fuse Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fuse with respect to the benefits of owning Fuse Medical security.